Literature DB >> 27245503

Prostate cancer: Combining endocrine treatment and radiotherapy: a bright future.

Mack Roach1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27245503     DOI: 10.1038/nrurol.2016.100

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported outcomes.

Authors:  Bo Lennernäs; Khairul Majumder; Jan-Erik Damber; Per Albertsson; Erik Holmberg; Yvonne Brandberg; Ulf Isacsson; Gunilla Ljung; Ole Damm; Sten Nilsson
Journal:  Acta Oncol       Date:  2014-11-02       Impact factor: 4.089

2.  Causes of death after radical prostatectomy at a large tertiary center.

Authors:  John Bernard Eifler; Elizabeth B Humphreys; Marilyn Agro; Alan W Partin; Bruce J Trock; Misop Han
Journal:  J Urol       Date:  2012-07-20       Impact factor: 7.450

Review 3.  Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy?

Authors:  Gustavo Arruda Viani; Lucas Godói Bernardes da Silva; Eduardo Jose Stefano
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-07-15       Impact factor: 7.038

4.  Overview of randomized controlled treatment trials for clinically localized prostate cancer: implications for active surveillance and the United States preventative task force report on screening?

Authors:  Mack Roach; Kimberly Thomas
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

5.  Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years.

Authors:  Peter Iversen; David G McLeod; William A See; Thomas Morris; Jon Armstrong; Manfred P Wirth
Journal:  BJU Int       Date:  2010-04       Impact factor: 5.588

6.  Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7.

Authors:  Sophie D Fosså; Fredrik Wiklund; Olbjørn Klepp; Anders Angelsen; Arne Solberg; Jan-Erik Damber; Morten Hoyer; Anders Widmark
Journal:  Eur Urol       Date:  2016-03-26       Impact factor: 20.096

7.  Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials.

Authors:  Christopher R King; Debra Freeman; Irving Kaplan; Donald Fuller; Giampaolo Bolzicco; Sean Collins; Robert Meier; Jason Wang; Patrick Kupelian; Michael Steinberg; Alan Katz
Journal:  Radiother Oncol       Date:  2013-09-20       Impact factor: 6.280

8.  Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial.

Authors:  David F Penson; Andrew J Armstrong; Raoul Concepcion; Neeraj Agarwal; Carl Olsson; Lawrence Karsh; Curtis Dunshee; Fong Wang; Kenneth Wu; Andrew Krivoshik; De Phung; Celestia S Higano
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

Review 9.  Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer.

Authors:  Frank Kunath; Henrik R Grobe; Gerta Rücker; Edith Motschall; Gerd Antes; Philipp Dahm; Bernd Wullich; Joerg J Meerpohl
Journal:  Cochrane Database Syst Rev       Date:  2014-06-30

Review 10.  Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy for Clinically Localized Prostate Cancer: How Good Is the Evidence?

Authors:  Mack Roach; Tania L Ceron Lizarraga; Ann A Lazar
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-11-11       Impact factor: 7.038

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.